Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investments (Tables)

9 Months Ended

Sep. 30, 2024

Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investments

Schedule of marketable investment securities, restricted cash and cash equivalents, and other investments

	As of
	September 30,		December 31,
	2024		2023
	(In thousands)
Marketable investment securities:
Current marketable investment securities:
Strategic - available-for-sale	$	51	$	144
Strategic - trading/equity		10		7,799
Other		111		179
Total current marketable investment securities		172		8,122
Restricted marketable investment securities (1)		10,785		19,772
Total marketable investment securities		10,957		27,894
Restricted cash and cash equivalents (1) (2)		2,162,117		89,107
Other investments, net:
Equity method investments (3)		19,388		126,179
Cost method investments		5,648		3,448
Fair value method investments		39,291		39,198
Total other investments, net		64,327		168,825
Total marketable investment securities, restricted cash and cash equivalents, and other investments, net	$	2,237,401	$	285,826

(1) Restricted marketable investment securities and restricted cash and cash equivalents are included in “Current restricted cash and cash equivalents” and “Restricted cash, cash equivalents and marketable investment securities” on our Condensed Consolidated Balance Sheets.

(2) Includes $2.047 billion in proceeds received from the New DBS Financing, as detailed and defined in Note 8.

(3) This change primarily resulted from the Sale and Transfer of Assets to EchoStar, see Note 1 for further information, and the decrease in our Invidi Technologies Corporation investment, discussed below.

Schedule of fair value measurements

	As of
	September 30, 2024								December 31, 2023
	Total		Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3
	(In thousands)
Cash equivalents (including restricted)	$	2,168,058	$	85,330	$	2,082,728	$	—	$	347,976	$	304,410	$	43,566	$	—
Debt securities (including restricted):
U.S. Treasury and agency securities	$	10,785	$	10,785	$	—	$	—	$	7,567	$	7,567	$	—	$	—
Commercial paper		—		—		—		—		7,500		—		7,500		—
Corporate securities		—		—		—		—		4,705		—		4,705		—
Other		162		—		111		51		323		—		179		144
Equity securities		10		10		—		—		7,799		7,799		—		—
Total	$	10,957	$	10,795	$	111	$	51	$	27,894	$	15,366	$	12,384	$	144

Schedule of gains and losses on sales and changes in carrying amounts of investments and other

	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
Other, net:	2024		2023		2024		2023
	(In thousands)
Marketable and non-marketable investment securities - realized and unrealized gains (losses)	$	(8)	$	20	$	(922)	$	1,432
Sale of Assets to EchoStar - realized gains (losses)		—		—		128,788		—
Derivative instruments - net realized and/or unrealized gains (losses)		—		(155,133)		—		(192,107)
Gains (losses) related to early redemption of debt		—		4,480		—		72,566
Equity in earnings (losses) of affiliates		(3,345)		(1,216)		(68,257)		(3,596)
Liberty Puerto Rico Asset Sale (Note 9)		21,310		—		21,310		—
Other		62		352		(35)		979
Total	$	18,019	$	(151,497)	$	80,884	$	(120,726)